Loading...
XNYS
CAH
Market cap47bUSD
Dec 04, Last price  
199.19USD
1D
-0.26%
1Q
33.18%
Jan 2017
176.77%
Name

Cardinal Health Inc

Chart & Performance

D1W1MN
XNYS:CAH chart
P/E
30.32
P/S
0.21
EPS
6.57
Div Yield, %
1.01%
Shrs. gr., 5y
-3.75%
Rev. gr., 5y
7.80%
Revenues
222.58b
-1.87%
81,363,600,00086,852,000,00091,091,400,00099,512,400,00098,502,800,000102,644,200,000107,552,000,000101,093,000,00091,084,000,000102,531,000,000121,546,000,000129,976,000,000136,809,000,000145,534,000,000152,922,000,000162,467,000,000181,364,000,000205,012,000,000226,827,000,000222,578,000,000
Net income
1.56b
+83.22%
1,000,100,0001,931,100,0001,300,600,0001,151,600,000642,200,000959,000,0001,069,000,000334,000,0001,166,000,0001,215,000,0001,427,000,0001,288,000,000256,000,0001,363,000,000-3,693,000,000611,000,000-932,000,000261,000,000852,000,0001,561,000,000
CFO
2.40b
-36.28%
2,140,300,0001,223,100,0001,512,100,0001,567,300,0002,134,100,0001,394,600,0001,176,000,0001,727,000,0002,524,000,0002,540,000,0002,971,000,0001,184,000,0002,768,000,0002,722,000,0001,960,000,0002,429,000,0003,122,000,0002,839,000,0003,762,000,0002,397,000,000
Dividend
Oct 01, 20240.5056 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
IPO date
Aug 04, 1983
Employees
47,040
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT